Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring
Manuel De Jesus, Trainee in Polymer Sciences and Advanced Materials at the Center for Graduate Studies and Research in Chemistry (CGIQ), shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Scientific advancement depends not only on developing new technologies, but also on validating and verifying their performance to ensure reliable, accurate, and reproducible results in real-world applications.
I’m pleased to share the publication of our scientific work:
‘Experimental Research and Development of the Validation and Verification (V&V) of a Miniaturized and Optimized Micro-Rheological Device for Point-of-Care Testing (POCT)-Based Anemia Monitoring in Clinical Settings.’ — July 2026
This work presents the experimental validation and verification of a miniaturized micro-rheological device developed for point-of-care hematocrit assessment and anemia monitoring in clinical settings.
The proposed system exploits the relationship between whole-blood viscosity and hematocrit, integrating controlled microfluidic flow with a calibrated visual interpretation method to obtain quantitative results. A structured V&V framework was implemented to evaluate mechanical, thermal, and fluidic stability, as well as analytical performance against the conventional centrifugation-based reference method.
Experimental evaluation demonstrated a strong agreement with the standard method, achieving high precision, repeatability, and operational stability across clinically representative samples. These results support the potential of the proposed technology as a simplified, reliable, and scalable approach for rapid hematocrit estimation and point-of-care applications.
The development and validation of miniaturized diagnostic technologies represents an important step toward making clinical testing more accessible, efficient, and adaptable to decentralized healthcare environments.
From experimental research to technological validation, engineering innovation becomes meaningful when it contributes to better and more accessible healthcare.
Engineering innovation begins with transforming scientific research into reliable solutions for real-world challenges.”
Title: Experimental Research and Development of the Validation and Verification (V&V) of a Miniaturized and Optimized Micro-Rheological Device for Point-of-Care Testing (POCT)-Based Anemia Monitoring in Clinical Settings
Authors: Manuel De Jesus Cardenas Medina, Jesús Francisco Cueto Beristain, Gael Ramírez Zavala
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD